Nektar therapeutics (NKTR)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Revenue:
Total revenue

50,573

33,862

29,218

23,315

28,222

39,826

27,762

1,087,717

38,018

95,466

152,928

34,589

24,728

37,450

36,336

32,768

58,882

39,370

59,952

22,661

108,801

19,552

132,871

28,513

19,771

31,146

60,909

33,862

23,004

21,146

18,412

23,684

17,949

15,782

27,068

17,331

11,299

45,314

37,925

42,563

33,237

Product sales

-

-

-

-

-

-

-

-

-

-

-

-

4,756

-

14,698

12,867

14,099

13,973

7,240

10,968

7,974

-

-

-

-

-

-

-

-

10,405

8,355

9,694

6,945

-

-

-

-

-

-

-

-

Royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

7,217

-

5,573

3,516

4,061

1,910

187

745

125

-

-

-

-

-

-

-

-

909

498

290

3,177

-

-

-

-

-

-

-

-

Product sales and royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,172

5,891

5,917

-

15,026

10,675

12,135

-

-

-

-

-

10,222

11,008

4,793

-

7,230

11,154

3,584

Non-cash royalty revenue related to sale of future royalties

-

-

-

-

-

-

-

-

-

-

-

-

6,663

-

7,692

8,115

6,535

7,306

6,050

4,740

3,962

5,184

6,143

4,837

5,773

9,311

4,523

3,828

4,393

-

3,427

3,469

-

-

-

-

-

-

-

-

-

License, collaboration and other revenue

-

-

-

-

-

-

-

-

-

-

-

-

6,092

-

8,373

8,270

34,187

16,181

46,475

6,208

96,740

6,867

120,556

17,785

8,081

13,677

41,360

19,359

6,476

5,937

6,132

10,231

7,827

6,614

16,846

6,323

6,506

32,615

30,695

31,409

29,653

Operating costs and expenses:
Cost of goods sold

3,811

5,989

4,927

5,018

5,440

7,461

4,783

5,522

6,646

-

-

-

6,131

6,604

7,033

7,708

8,870

8,364

6,760

10,534

8,444

6,298

9,220

5,108

7,907

8,960

12,877

5,011

11,661

7,290

7,228

7,203

8,707

5,450

5,038

8,140

3,263

10,237

6,245

4,889

4,296

Research and development

108,987

110,369

99,048

106,686

118,463

108,883

102,895

88,334

99,424

81,429

65,714

60,260

61,058

50,232

51,951

52,350

49,268

47,135

43,229

45,412

47,011

38,494

34,200

36,702

38,338

48,248

43,914

52,230

45,618

46,373

34,016

33,201

35,085

33,302

31,018

32,270

30,176

31,455

27,724

25,600

23,286

General and administrative

26,217

27,142

23,983

22,581

25,006

23,777

18,718

20,261

18,687

12,337

12,055

15,996

11,976

12,759

10,253

11,035

10,228

13,235

9,544

10,184

10,303

12,248

9,130

9,619

9,928

9,834

10,643

9,226

10,829

10,864

10,068

10,268

10,414

11,498

12,350

11,185

11,727

11,585

10,181

10,207

9,013

Impairment of assets and other costs for terminated program

45,189

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,675

-

-

-

-

-

-

-

-

Total operating costs and expenses

184,204

143,500

127,958

134,285

148,909

140,121

126,396

114,117

124,757

119,500

83,443

85,245

79,165

69,595

69,237

71,093

68,366

68,734

59,533

66,130

65,758

57,040

52,550

51,429

56,173

67,042

67,434

66,467

68,108

64,527

51,312

50,672

55,881

50,250

48,406

51,595

45,166

65,853

44,150

40,696

36,595

Loss from operations

-133,631

-109,638

-98,740

-110,970

-120,687

-100,295

-98,634

973,600

-86,739

-24,034

69,485

-50,656

-54,437

-32,145

-32,901

-38,325

-9,484

-29,364

419

-43,469

43,043

-37,488

80,321

-22,916

-36,402

-35,896

-6,525

-32,605

-45,104

-43,381

-32,900

-26,988

-37,932

-34,468

-21,338

-34,264

-33,867

-20,539

-6,225

1,867

-3,358

Non-operating income (expense):
Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

116

209

314

-

603

630

632

661

622

529

432

320

369

393

463

Interest expense

6,204

5,428

5,425

5,231

5,226

5,415

5,442

5,385

5,340

5,633

5,540

5,510

5,402

5,550

5,614

5,627

5,677

5,791

4,202

4,118

4,171

4,457

4,391

4,488

4,533

4,565

4,587

4,656

4,645

4,682

5,697

2,562

2,548

2,525

2,543

2,570

2,585

2,488

2,826

2,909

2,951

Non-cash interest expense on liability related to sale of future royalties

7,000

7,112

5,813

5,975

6,100

6,392

4,814

4,975

5,019

5,365

4,471

4,512

4,552

4,783

4,902

4,982

5,045

5,191

5,226

5,152

5,050

5,164

5,203

5,134

5,387

5,665

5,616

5,485

5,543

5,416

5,487

5,369

1,785

-

-

-

-

-

-

-

-

Interest income and other income (expense), net

8,352

10,371

11,492

11,989

12,483

12,048

11,847

12,105

1,571

1,357

1,599

906

658

722

332

458

875

325

898

246

211

280

126

96

312

741

262

-6

127

2,385

156

97

660

-445

-717

-16

134

391

249

163

24

Total non-operating income (expense), net

-4,820

-2,248

254

783

1,192

245

1,591

1,745

-8,788

-9,610

-8,412

-9,116

-9,296

-9,611

-10,184

-10,151

-9,847

-24,736

-8,530

-9,024

-9,010

-9,341

-9,468

-9,526

-9,608

-10,128

-9,825

-9,938

-9,747

-9,578

-10,425

-7,204

-3,041

-2,309

-2,638

-2,057

-2,019

-1,777

-2,208

-2,353

-2,464

Loss before provision for income taxes

-138,451

-111,886

-98,486

-110,187

-119,495

-100,050

-97,043

975,345

-95,527

-33,644

61,073

-59,772

-63,733

-41,756

-43,085

-48,476

-19,331

-54,100

-8,111

-52,493

34,033

-46,829

70,853

-32,442

-46,010

-46,024

-16,350

-42,543

-54,851

-52,959

-43,325

-34,192

-40,973

-36,777

-23,976

-36,321

-35,886

-22,316

-8,433

-486

-5,822

Provision for income taxes

200

432

322

-278

137

-1,838

-900

3,885

265

182

202

99

133

443

139

127

167

37

92

164

213

-1,146

248

195

191

1,635

193

205

212

-33

222

93

124

718

92

60

148

264

278

31

308

Net loss

-138,651

-112,318

-98,808

-109,909

-119,632

-98,212

-96,143

971,460

-95,792

-33,826

60,871

-59,871

-63,866

-42,199

-43,224

-48,603

-19,498

-54,137

-8,203

-52,657

33,820

-45,683

70,605

-32,637

-46,201

-47,659

-16,543

-42,748

-55,063

-52,926

-43,547

-34,285

-41,097

-37,495

-24,068

-36,381

-36,034

-22,580

-8,711

-517

-6,130

Basic and diluted net loss per share (in dollars per share)

-0.78

-

-

-

-0.69

-

-

-

-0.60

-

-

-

-0.42

-

-

-0.36

-0.14

-

-0.06

-0.40

-

-

-

-0.26

-

-

-

-0.37

-0.48

0.00

-0.38

-0.30

-0.36

0.00

-0.21

-0.32

-0.33

0.00

-0.09

-0.01

-0.07

Weighted average shares outstanding used in computing basic and diluted net loss per share (in shares)

177,185

-

-

-

173,859

-

-

-

160,884

-

-

-

153,666

-

-

136,350

135,793

-

132,631

131,643

-

-

-

127,040

-

-

-

115,544

115,309

115,185

114,915

114,649

114,531

114,525

114,413

114,153

108,677

94,407

94,213

94,065

93,631

Net income (loss) per share
Basic ( in dollars per share)

-

-

-0.56

-0.63

-

-

-0.56

5.67

-

-

0.39

-0.39

-

-

-0.32

-

-

-

-

-

0.26

-

0.55

-

-0.37

-

-0.14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in dollars per share)

-

-

-0.56

-0.63

-

-

-0.56

5.33

-

-

0.37

-0.39

-

-

-0.32

-

-

-

-

-

0.25

-

0.53

-

-0.37

-

-0.14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding used in computing net income (loss) per share
Basic (in shares)

-

-

175,402

174,549

-

-

172,698

171,378

-

-

156,411

155,352

-

-

137,094

-

-

-

-

-

131,359

-

127,504

-

123,543

-

115,812

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in shares)

-

-

175,402

174,549

-

-

172,698

182,291

-

-

162,641

155,352

-

-

137,094

-

-

-

-

-

135,667

-

132,177

-

123,543

-

115,812

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales
Total revenue

3,444

5,815

5,558

4,346

4,398

4,360

4,256

5,863

6,295

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty revenue
Total revenue

9,719

12,214

10,275

7,343

11,390

12,078

10,259

8,563

11,076

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash royalty revenue related to sale of future royalties
Total revenue

9,895

8,718

10,264

9,091

8,230

8,971

8,372

9,045

6,920

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License, collaboration and other revenue
Total revenue

27,515

7,115

3,121

2,535

4,204

14,417

4,875

1,064,246

13,727

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-